Recent articles
2 Top Augmented Reality Stocks to Buy Right Now
Investors in this space should buy financially strong AR companies with platforms that can drive adoption.
This Robotics Stock Spiked 30% in One Day -- Is It a Buy?
A new kind of software called Robotic Process Automation is coming into its own and Blue Prism hopes to take advantage.
How You Can Profit From Ubiquiti's War on Wall Street
The company has high interest from short-sellers. That's good news because all those shorts will have to buy this rising tech stock.
2 Top Tech Stocks to Buy in December
Whether you want to visit cyberspace or outer space, these companies can get you there.
Better Buy: Shopify vs. Veeva Systems
Which of these SaaS titans is more worthy of your investing dollars?
2 Top Biotech Stocks to Buy Right Now
Here's why you might want to buy Amarin and Blueprint Medicines as soon as possible.
Better Buy: Novavax vs. Inovio Pharmaceuticals
These two pharma micro-caps are approaching climactic phase 3 trials.
3 Top Fintech Stocks to Buy in November
See why Afterpay, StoneCo, and Zillow might be the right fintech stocks for you to invest in.
3 Top Healthcare Stocks to Buy in November
InMode, Amarin, and Arrowhead Pharmaceuticals are small-cap healthcare stocks working wonders right now.
3 Top Stocks Under $20
See why Glu Mobile, MeiraGTx, and Enphase Energy should be on your shopping list.
Better Buy: Disney vs. Netflix
Will Netflix remain the king of all streaming, or will Disney topple the upstart?
Where Will Square Be in 10 Years?
It might morph into an incredibly valuable financial services company, or even a super-bank.
2 Stocks That Are Absurdly Cheap Right Now
The stock market is severely underpricing a gaming stock for your smart phone and a speed-boat manufacturer.
3 Cancer Treatment Stocks to Buy Right Now
MIrati Therapeutics, Iovance Biotherapeutics, and Personalis are all using genetic knowledge to help find cures for cancer.
Could Novavax Be a Millionaire-Maker Stock?
This tiny biotech has a long history of failure, but it also has a flu vaccine that is likely to be approved by the FDA.
Is Smartsheet in Danger of Being Crushed by Microsoft?
Microsoft has a flaw, and tiny Smartsheet is taking advantage of it.
Is It Time to Buy Ubisoft?
This French video-game company's stock has taken a big hit, but we like what it has in store.
1 No-Brainer Pharmaceutical Stock to Buy
It's highly likely that Immunomedics' billion-dollar drug will finally be approved by the FDA.
Why Orthodontists Are Scared of SmileDirectClub
An online startup is disrupting an industry with a cheaper and easier alternative.
Why Shockwave Medical Is Not a Buy
It's an amazing company with fantastic revenue growth. But there's one small problem that's keeping me on the sidelines.